tiprankstipranks
Trending News
More News >
Scandinavian ChemoTech AB Class B (DE:8V6)
FRANKFURT:8V6
Germany Market

Scandinavian ChemoTech AB Class B (8V6) Financial Statements

Compare
0 Followers

Scandinavian ChemoTech AB Class B Financial Overview

Scandinavian ChemoTech AB Class B's market cap is currently €3.08M. The company's EPS TTM is €-0.054; its P/E ratio is ―; Scandinavian ChemoTech AB Class B is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 6.57Mkr 2.82Mkr 473.00Kkr 49.00Kkr 131.00K
Gross Profitkr 4.78Mkr 1.66Mkr -55.00Kkr 323.00Kkr -14.00K
Operating Incomekr -12.80Mkr -20.24Mkr -20.91Mkr -17.08Mkr -10.83M
EBITDAkr -10.73Mkr -19.58Mkr -20.81Mkr -17.03Mkr -10.77M
Net Incomekr -13.72Mkr -21.09Mkr -24.58Mkr -18.42Mkr -12.50M
Balance Sheet
Cash & Short-Term Investmentskr 949.00Kkr 923.00Kkr 5.85Mkr 8.68Mkr 1.49M
Total Assetskr 13.38Mkr 14.87Mkr 21.70Mkr 25.81Mkr 15.99M
Total Debtkr 0.00kr 0.00kr 0.00kr 53.00Kkr 2.71M
Net Debtkr -949.00Kkr -923.00Kkr -5.85Mkr -8.63Mkr 1.23M
Total Liabilitieskr 7.40Mkr 3.84Mkr 7.71Mkr 1.89Mkr 6.75M
Stockholders' Equitykr 5.98Mkr 11.03Mkr 13.99Mkr 23.92Mkr 9.24M
Cash Flow
Free Cash Flowkr -13.14Mkr -18.91Mkr -19.96Mkr -22.36Mkr -10.32M
Operating Cash Flowkr -13.14Mkr -18.23Mkr -19.63Mkr -19.18Mkr -8.49M
Investing Cash Flowkr -2.00Kkr -468.00Kkr -603.00Kkr -3.33Mkr -1.83M
Financing Cash Flowkr 13.17Mkr 13.77Mkr 17.26Mkr 29.71Mkr 8.98M
Currency in SEK

Scandinavian ChemoTech AB Class B Earnings and Revenue History

Scandinavian ChemoTech AB Class B Debt to Assets

Scandinavian ChemoTech AB Class B Cash Flow

Scandinavian ChemoTech AB Class B Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis